Paid Clinical Trials Toronto

Discover 1,989 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,989

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Toronto, Barrie, London, Fort Gratiot MIshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Daratumumab vs. DaratumumabFixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Toronto, Brampton, Newmarket, Oshawashow 16 more

Code:

NCT06182774

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Daratumumab

Lenalidomide

Dexamethasone

Observational StudyThe Young Adult Clinic (YAC) Study

Recruiting

Sponsor:

Women's College Hospital

Location:

Toronto

Code:

NCT05147974

Conditions

Insomnia

Chronic Pain

Insomnia Due to Medical Condition

Eligibility Criteria

Sex: All

Age: 18 - 25

Healthy Volunteers: Not accepted

Interventions

DOZE app

CECAAutologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency

Recruiting

Sponsor:

CHU de Quebec-Universite Laval

Location:

Toronto, Montreal, Quebec

Code:

NCT01756365

Conditions

Limbal Stem Cell Deficiency

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

Surgical transplantation of ACCE

Sentinel Lymph Node BiopsySentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT06085274

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ICG guided sentinel lymph node biopsy

Axatilimab & CorticosteroidsA Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Toronto, Detroit MI, Morgantown WV, Hackensack NJshow 9 more

Code:

NCT06585774

Conditions

Chronic Graft-versus-host-disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

INCA034176

Placebo

Corticosteroids

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Toronto, Cleveland OH, Clinton Township MI, Westlake OHshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

PIB vs. CIPIB Versus CI Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle Surgery

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT02707874

Conditions

Pain, Postoperative

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

CI 0.2% ropivacaine

PIB 0.2% ropivacaine

PRG with GastropexyPRG With and Without Gastropexy

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT04107974

Conditions

Gastrostomy

Gastrostomy Complications

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gastropexy.

Non-Gastropexy

Olutasidenib & TemozolomideStudy of Olutasidenib and Temozolomide in HGG

Recruiting

PHASE2

Sponsor:

Rigel Pharmaceuticals

Location:

Toronto, Montreal, Columbus OH, Philadelphia PAshow 8 more

Code:

NCT06161974

Conditions

High Grade Glioma

Astrocytoma

Astrocytoma, Grade III

Astrocytoma, Grade IV

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 12 - 39

Healthy Volunteers: Not accepted

Interventions

Olutasidenib + TMZ